L&K Biomed Ltd. (KOSDAQ: 156100)

L&K Biomed Revenue

L&K Biomed had revenue of 9.75B KRW in the quarter ending September 30, 2024, with 38.07% growth. This brings the company's revenue in the last twelve months to 33.18B, up 17.56% year-over-year. In the year 2023, L&K Biomed had annual revenue of 29.90B with 51.28% growth.

• Revenue (ttm): 33.18B
• Revenue Growth: +17.56%
• P/S Ratio: 4.46
• Revenue / Employee: 553.07M
• Employees: 60
• Market Cap: 147.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%
Dec 31, 2020	19.36B	-7.22B	-27.16%
Dec 31, 2019	26.57B	-4.75B	-15.16%